Formulary
Carbomers: Indications, Dosing, Side Effects and Interactions
Carbomers clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Carbomers: Indications, Dosing, Side Effects and Interactions
Carbomers clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Dry eyes including keratoconjunctivitis sicca, unstable tear film (using 0.2% preparation)**
- **Child** (To The Eye): Apply 3-4 times a day, alternatively apply as required.
- **Adult** (To The Eye): Apply 3-4 times a day, alternatively apply as required.
**Dry eye conditions**
- **Child** (To The Eye): Apply 1-4 times a day.
- **Adult** (To The Eye): Apply 1-4 times a day.
**Dry eyes including keratoconjunctivitis sicca, unstable tear film (using 0.2% preparation) for carbomers**
- **Child** (To the eye): Apply 3-4 times a day, alternatively apply as required.
**Dry eye conditions for Liquivisc 0.25% eye gel**
- **Child** (To the eye): Apply 1-4 times a day.
Medicinal forms
Drops,Gel
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Carbomers in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

